|
FGD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.202280E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.812700E-04 |
| Normal-vs-Stage2 |
3.67109999954707E-07 |
| Normal-vs-Stage3 |
6.449000E-01 |
| Normal-vs-Stage4 |
9.337000E-01 |
| Stage1-vs-Stage2 |
7.199900E-03 |
| Stage1-vs-Stage3 |
5.228200E-01 |
| Stage1-vs-Stage4 |
1.991360E-01 |
| Stage2-vs-Stage3 |
8.157900E-02 |
| Stage2-vs-Stage4 |
1.074300E-02 |
| Stage3-vs-Stage4 |
7.509600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.761800E-03 |
| Normal-vs-AfricanAmerican |
6.406600E-01 |
| Normal-vs-Asian |
8.259100E-03 |
| Caucasian-vs-AfricanAmerican |
2.955000E-01 |
| Caucasian-vs-Asian |
1.316250E-02 |
| AfricanAmerican-vs-Asian |
1.524390E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.292400E-02 |
| Normal-vs-Female |
1.939220E-01 |
| Male-vs-Female |
2.605600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.049800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.325400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.629730E-04 |
| Normal-vs-Age(81-100Yrs) |
8.280400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.585400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.041600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.446400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.972750E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.854400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.608800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.442000E-01 |
| Normal-vs-Grade 2 |
3.63610000000403E-05 |
| Normal-vs-Grade 3 |
1.307750E-01 |
| Normal-vs-Grade 4 |
8.685600E-01 |
| Grade 1-vs-Grade 2 |
8.770300E-02 |
| Grade 1-vs-Grade 3 |
1.644800E-01 |
| Grade 1-vs-Grade 4 |
6.573200E-01 |
| Grade 2-vs-Grade 3 |
6.219400E-01 |
| Grade 2-vs-Grade 4 |
7.701800E-02 |
| Grade 3-vs-Grade 4 |
2.572400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62680979798324E-12 |
| Normal-vs-ccB subtype |
4.787400E-01 |
| ccA subtype-vs-ccB subtype |
2.431000E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.760800E-01 |
| Normal-vs-N1 |
6.297200E-01 |
| N0-vs-N1 |
3.528800E-01 |
|
|
